Your browser is no longer supported. Please, upgrade your browser.
Settings
EDGE Edge Therapeutics, Inc. daily Stock Chart
EDGE [NASD]
Edge Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.36 Insider Own3.10% Shs Outstand30.99M Perf Week-6.86%
Market Cap28.20M Forward P/E- EPS next Y-1.32 Insider Trans-4.98% Shs Float23.70M Perf Month-24.79%
Income-73.10M PEG- EPS next Q-0.53 Inst Own33.80% Short Float9.50% Perf Quarter-94.15%
Sales- P/S- EPS this Y-57.70% Inst Trans-31.18% Short Ratio1.23 Perf Half Y-90.81%
Book/sh1.43 P/B0.64 EPS next Y9.00% ROA-62.10% Target Price1.00 Perf Year-90.74%
Cash/sh2.42 P/C0.38 EPS next 5Y- ROE-89.70% 52W Range0.84 - 17.77 Perf YTD-90.29%
Dividend- P/FCF- EPS past 5Y-64.80% ROI- 52W High-94.88% Beta-
Dividend %- Quick Ratio2.30 Sales past 5Y- Gross Margin- 52W Low8.06% ATR0.08
Employees38 Current Ratio2.30 Sales Q/Q- Oper. Margin- RSI (14)37.03 Volatility7.70% 7.13%
OptionableYes Debt/Eq0.47 EPS Q/Q-60.40% Profit Margin- Rel Volume0.07 Prev Close0.90
ShortableYes LT Debt/Eq0.00 EarningsMay 31 BMO Payout- Avg Volume1.84M Price0.91
Recom4.00 SMA20-8.41% SMA50-76.25% SMA200-90.29% Volume133,144 Change0.88%
Jan-18-18Resumed Credit Suisse Outperform $17
Mar-03-17Resumed Leerink Partners Outperform $21
Oct-26-15Initiated Leerink Partners Outperform
Oct-26-15Initiated JMP Securities Mkt Outperform
Oct-26-15Initiated Credit Suisse Outperform
May-25-18 08:33PM  Who Really Owns Edge Therapeutics Inc (NASDAQ:EDGE)? Simply Wall St.
02:15PM  EDGE ALERT: Pawar Reminds of Important June 22, 2018 Lead Plaintiff Deadline in Class Action- EDGE ACCESSWIRE
11:00AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Edge Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 22, 2018 GlobeNewswire
10:19AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Edge Therapeutics, Inc. (EDGE) & Lead Plaintiff Deadline - June 25, 2018 ACCESSWIRE
May-22-18 03:05PM  The Klein Law Firm Notifies Investors of a Class Action Commenced on Behalf of Edge Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of June 22, 2018 (EDGE) ACCESSWIRE
May-18-18 04:00PM  EDGE Deadline: Bernstein Liebhard LLP Reminds Investors Of Important Deadline In Class Action Against Edge Therapeutics, Inc. - EDGE GlobeNewswire
03:48PM  EQUITY NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Edge Therapeutics, Inc. Business Wire
03:08PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Edge Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 22, 2018 ACCESSWIRE
May-17-18 03:35PM  EDGE EQUITY ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Edge Therapeutics, Inc. and a Lead Plaintiff Deadline of June 22, 2018 ACCESSWIRE
01:55PM  EDGE DEADLINE: Pawar Law Reminds Investors of Important June 22, 2018 Lead Plaintiff Deadline in Class Action- EDGE ACCESSWIRE
10:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Edge Therapeutics, Inc. (EDGE) & Lead Plaintiff Deadline June 25, 2018 GlobeNewswire
May-16-18 04:20PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Edge Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 22, 2018 ACCESSWIRE
May-15-18 04:45PM  IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
03:00PM  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Edge Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of June 22, 2018 (EDGE) Business Wire
May-14-18 03:10PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Edge Therapeutics, Inc. (EDGE) and Encourages Investors to Contact the Firm Business Wire
03:00PM  EDGE INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Edge Therapeutics, Inc. and a Lead Plaintiff Deadline of June 22, 2018 Business Wire
May-11-18 04:59PM  EDGE LOSS NOTICE: Rosen Law Reminds Edge Therapeutics, Inc. Investors of Important Deadline in Class Action EDGE Business Wire
11:55AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Edge Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 22, 2018 Business Wire
10:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Edge Therapeutics, Inc. (EDGE) & Lead Plaintiff Deadline - June 25, 2018 ACCESSWIRE
May-10-18 05:10PM  PAWAR LAW - Edge Therapeutics, Inc. - June 22, 2018 Deadline in Class Action - EDGE ACCESSWIRE
04:00PM  The Klein Law Firm Announces a Class Action Filed on Behalf of Edge Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of June 22, 2018 (EDGE) Business Wire
11:25AM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
May-09-18 02:22PM  The Klein Law Firm Announces a Class Action Filed on Behalf of Edge Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of June 22, 2018 (EDGE) GlobeNewswire
10:50AM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm ACCESSWIRE
May-08-18 07:35PM  SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
04:45PM  EDGE SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Edge Therapeutics, Inc. and a Lead Plaintiff Deadline of June 22, 2018 Business Wire
May-07-18 03:45PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
May-04-18 05:02PM  EDGE SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Edge Therapeutics, Inc. and a Lead Plaintiff Deadline of June 22, 2018 GlobeNewswire +6.87%
10:37AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Edge Therapeutics, Inc. (EDGE) & Lead Plaintiff Deadline - June 25, 2018 ACCESSWIRE
May-03-18 04:00PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Edge Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 22, 2018 Business Wire
May-02-18 01:40PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
12:25PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Edge Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 22, 2018 GlobeNewswire
11:15AM  Lawsuit for Investors in Edge Therapeutics, Inc. (NASDAQ: EDGE) Shares Announced by Shareholders Foundation ACCESSWIRE
May-01-18 07:25PM  INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE -8.64%
05:29PM  The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Edge Therapeutics, Inc. (EDGE) Business Wire
03:30PM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Edge Therapeutics, Inc. - EDGE ACCESSWIRE
06:45AM  Edge Therapeutics: 1Q Earnings Snapshot Associated Press
06:30AM  Edge Therapeutics Reports First Quarter 2018 Financial Results GlobeNewswire
Apr-30-18 05:20PM  The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Edge Therapeutics, Inc. (EDGE) Business Wire -5.17%
04:04PM  Edge Shareholders: Bernstein Liebhard LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Edge Therapeutics, Inc. - EDGE GlobeNewswire
07:00AM  Edge Therapeutics Announces Review of Strategic Alternatives GlobeNewswire
Apr-27-18 06:36PM  EDGE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Edge Therapeutics, Inc. To Contact The Firm GlobeNewswire
05:50PM  EDGE INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Edge Therapeutics, Inc. Business Wire
01:00PM  INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:36AM  EQUITY ALERT: Rosen Law Announces Filing of Securities Class Action Lawsuit Against Edge Therapeutics, Inc. EDGE Business Wire
Apr-26-18 06:11PM  Robbins Arroyo LLP: Edge Therapeutics, Inc. (EDGE) Misled Shareholders According to a Recently Filed Class Action Business Wire +5.22%
03:03PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Edge Therapeutics, Inc. GlobeNewswire
12:43PM  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Edge Therapeutics, Inc. Business Wire
10:37AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Edge Therapeutics, Inc. (EDGE) & Lead Plaintiff Deadline - June 25, 2018 ACCESSWIRE
Apr-25-18 01:57PM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Edge Therapeutics, Inc. (EDGE) and Encourages Investors to Contact the Firm Business Wire
01:33PM  Edge Shareholder Alert: Bernstein Liebhard LLP Announces That A Class Action Lawsuit Has Been Filed Against Edge Therapeutics, Inc. - EDGE PR Newswire
10:49AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors Edge Therapeutics, Inc. -- EDGE Business Wire
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Edge Therapeutics, Inc. (EDGE) & Lead Plaintiff Deadline - June 25, 2018 PR Newswire
Apr-24-18 06:44PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors Edge Therapeutics, Inc. Business Wire
03:27PM  INVESTOR ALERT: Kirby McInerney LLP Announces a Securities Class Action on Behalf of Edge Therapeutics, Inc. Investors Business Wire
12:41PM  Lifshitz & Miller LLP Announces Investigation of ADT Inc., AveXis, Inc., Connecticut Water Service, Inc., Edge Therapeutics, Inc., Fairmount Santrol Holdings, Inc., Oclaro, Inc., QuinStreet, Inc. and RSP Permian, Inc. PR Newswire
Apr-23-18 08:30PM  Glancy Prongay & Murray LLP Files a Securities Class Action on Behalf of Edge Therapeutics, Inc. Investors (EDGE) Business Wire +9.65%
05:56PM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of Edge Therapeutics, Inc. Investors (EDGE) Business Wire
Apr-16-18 02:58PM  EDGE INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Edge Therapeutics, Inc. Investors Business Wire +5.45%
Apr-12-18 08:34PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Edge Therapeutics, Inc. Investors (EDGE) Business Wire
Apr-04-18 10:56AM  Biotech Stock Roundup: EDGE Falls, ALKS Down, FDA OK's AMGN Drug Label Expansion Zacks +14.71%
Apr-02-18 10:25AM  Edge Therapeutics Loses Edge on Failure of Late-Stage Study Zacks -8.47%
Mar-29-18 05:28PM  EDGE INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Edge Therapeutics, Inc. Investors Business Wire -9.92%
11:32AM  Credit Suisse Slashes Edge Therapeutics Price Target By 94%, Downgrades Stock After Failed Trial Benzinga
09:34AM  Investor Alert: Kaplan Fox Announces Investigation Of Edge Therapeutics, Inc. PR Newswire
06:31AM  Edge Therapeutics And Apricus Biosciences Are Moving: Heres Why Market Exclusive
Mar-28-18 06:18PM  EDGE THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Edge Therapeutics, Inc. To Contact The Firm PR Newswire -91.60%
04:47PM  Why Tesla, Amazon.com, and Edge Therapeutics Slumped Today Motley Fool
12:53PM  Here's Why Edge Therapeutics Stock Collapsed Today Motley Fool
08:49AM  Edge Therapeutics's stock plummets on heavy volume after late-stage drug trial discontinued MarketWatch
07:00AM  Edge Therapeutics Provides Update following Interim Analysis of Phase 3 NEWTON 2 Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage GlobeNewswire
Mar-02-18 01:00AM  Edited Transcript of EDGE earnings conference call or presentation 1-Mar-18 1:30pm GMT Thomson Reuters StreetEvents
Mar-01-18 07:05AM  Edge Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
06:49AM  Edge Therapeutics reports 4Q loss Associated Press
06:30AM  Edge Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
Feb-28-18 09:47AM  When Can We Expect A Profit From Edge Therapeutics Inc (NASDAQ:EDGE)? Simply Wall St.
Feb-26-18 07:00AM  Edge Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results Conference Call on March 1, 2018 GlobeNewswire
Feb-08-18 07:00AM  Edge Therapeutics to Present at Upcoming Investor Conferences in February GlobeNewswire
Dec-29-17 04:05PM  Edge's EG-1962 Phase 3 NEWTON 2 Study Continues as Planned Following Completion of Futility Analysis GlobeNewswire
Nov-28-17 04:26PM  Edited Transcript of EDGE earnings conference call or presentation 1-Nov-17 12:30pm GMT Thomson Reuters StreetEvents
Nov-06-17 07:00AM  Edge Therapeutics to Present at the 26th Annual Credit Suisse Healthcare Conference GlobeNewswire
Nov-01-17 07:55AM  Is Edge Therapeutics Incs (EDGE) Balance Sheet A Threat To Its Future? Simply Wall St.
07:05AM  Edge Therapeutics reports 3Q loss Associated Press
07:00AM  Edge Therapeutics Reports Third Quarter 2017 Financial Results GlobeNewswire
Oct-18-17 07:00AM  Edge Therapeutics Announces Third Quarter Financial Results Conference Call on November 1, 2017 GlobeNewswire
Oct-06-17 07:00AM  Edge Therapeutics to Present at the Neurocritical Care Society 15th Annual Meeting GlobeNewswire
Sep-20-17 07:00AM  Edge Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire
Sep-19-17 07:00AM  Edge Therapeutics Appoints Rosemary A. Crane, Pharmaceutical Industry Leader, to its Board of Directors GlobeNewswire
Aug-16-17 06:15PM  Edited Transcript of EDGE earnings conference call or presentation 1-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-01-17 10:59PM  Edge Therapeutics reports 2Q loss Associated Press
06:45AM  Investor Network: Edge Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
06:30AM  Edge Therapeutics Reports Second Quarter 2017 Financial Results and Continued Operational Progress GlobeNewswire
Jul-29-17 06:45AM  3 Biotech Stocks for Enterprising Investors Motley Fool
Jul-18-17 07:00AM  Edge Therapeutics Announces Second Quarter Financial Results Conference Call on August 1, 2017 GlobeNewswire
Jul-06-17 06:30AM  Edge Therapeutics Announces Commercial Supply Agreement for EG-1962 with Oakwood Laboratories GlobeNewswire
Jun-15-17 07:00AM  Edge Therapeutics to Participate in the JMP Securities Life Science Conference GlobeNewswire
Jun-08-17 06:30AM  Edge Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency GlobeNewswire
Jun-02-17 07:00AM  Edge Therapeutics to Present at Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-10-17 07:00AM  Edge Therapeutics to Present at Bank of America Merrill Lynch 2017 Health Care Conference GlobeNewswire
May-04-17 08:45AM  Edited Transcript of EDGE earnings conference call or presentation 3-May-17 12:30pm GMT Thomson Reuters StreetEvents
Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and seeks to commercialize hospital-based therapies for acute life-threatening neurological and other conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company is also developing EG-1964, as a prophylactic treatment for the management of chronic subdural hematoma to prevent recurrent bleeding on the surface of the brain; and EG-1965, for the prevention of post-operative atrial fibrillation. Edge Therapeutics, Inc. was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Macdonald R. LochChief Scientific OfficerMar 22Sale16.412,50041,025570,602Mar 22 04:03 PM
Macdonald R. LochChief Scientific OfficerMar 21Sale16.522,50041,300573,102Mar 21 11:34 AM
Macdonald R. LochChief Scientific OfficerMar 20Sale16.475,00082,350575,602Mar 21 11:34 AM
Macdonald R. LochChief Scientific OfficerMar 19Sale16.662,50041,650580,602Mar 21 11:34 AM
Leuthner Brian APresident and CEOMar 02Sale15.082,50037,70070,236Mar 05 08:19 AM
Leuthner Brian APresident and CEOMar 01Sale14.812,50037,02572,736Mar 05 08:19 AM
Leuthner Brian APresident and CEOFeb 23Sale15.372,50038,42575,236Feb 23 05:28 PM
Macdonald R. LochChief Scientific OfficerFeb 22Sale14.492,50036,225583,102Feb 22 05:00 PM
Leuthner Brian APresident and CEOFeb 22Sale15.472,50038,67577,736Feb 23 05:28 PM
Macdonald R. LochChief Scientific OfficerFeb 21Sale13.825,00069,100585,602Feb 22 05:00 PM
Macdonald R. LochChief Scientific OfficerFeb 20Sale13.755,00068,750590,602Feb 22 05:00 PM
Leuthner Brian APresident and CEOFeb 02Sale12.962,50032,40080,236Feb 02 09:15 PM
Leuthner Brian APresident and CEOFeb 01Sale13.142,50032,85082,736Feb 02 09:15 PM
Leuthner Brian APresident and CEOJan 03Sale10.112,50025,27585,236Jan 03 06:48 PM
Leuthner Brian APresident and CEOJan 02Sale10.112,50025,27587,736Jan 03 06:48 PM
Leuthner Brian APresident and CEODec 05Sale9.682,50024,20090,236Dec 05 05:39 PM
Leuthner Brian APresident and CEODec 04Sale9.972,50024,92592,736Dec 05 05:39 PM
Leuthner Brian APresident and CEODec 01Sale9.922,50024,80095,236Dec 05 05:39 PM
MARCHIO ALBERT N IIChief Accounting & Adm OfficerNov 22Sale10.003,36133,6100Nov 22 03:08 PM
Leuthner Brian APresident and CEONov 03Sale10.862,50027,15097,736Nov 03 05:53 PM
Leuthner Brian APresident and CEONov 02Sale10.942,50027,350100,236Nov 03 05:53 PM
Leuthner Brian APresident and CEONov 01Sale10.922,50027,300102,736Nov 03 05:53 PM
Leuthner Brian APresident and CEOOct 04Sale11.142,50027,850105,236Oct 04 05:52 PM
Leuthner Brian APresident and CEOOct 03Sale10.932,50027,325107,736Oct 04 05:52 PM
Leuthner Brian APresident and CEOOct 02Sale10.812,50027,025110,236Oct 04 05:52 PM
Leuthner Brian APresident and CEOSep 06Sale10.312,50025,775112,736Sep 06 08:01 PM
Leuthner Brian APresident and CEOSep 05Sale9.942,50024,850115,236Sep 06 08:01 PM
Leuthner Brian APresident and CEOSep 01Sale10.372,50025,925117,736Sep 06 08:01 PM
MARCHIO ALBERT N IIChief Accounting & Adm OfficerAug 29Sale10.422,50026,0503,361Aug 29 05:30 PM
MARCHIO ALBERT N IIChief Accounting & Adm OfficerAug 23Sale10.391,00010,3905,861Aug 24 04:11 PM
Leuthner Brian APresident and CEOAug 03Sale10.402,50026,000120,236Aug 03 08:45 PM
Leuthner Brian APresident and CEOAug 02Sale10.532,50026,325122,736Aug 03 08:45 PM
Leuthner Brian APresident and CEOAug 01Sale10.652,50026,625125,236Aug 03 08:45 PM
Leuthner Brian APresident and CEOJul 06Sale10.082,50025,200127,736Jul 06 05:50 PM
Leuthner Brian APresident and CEOJul 05Sale10.212,50025,525130,236Jul 06 05:50 PM
Leuthner Brian APresident and CEOJul 03Sale10.272,50025,675132,736Jul 06 05:50 PM